Background: Stenting of the ureterovesical anastomosis reduces the incidence of urological complications (UCs) after renal transplantation, but there are multiple stenting techniques, and there is no consensus regarding which technique is preferred. The aim of this study was to compare an internal versus an external stenting technique on the incidence of UCs. Methods: This is a retrospective analysis of 419 deceased donor renal transplantations performed between January 2008 and December 2013. Until 2011, 183 patients received an external stent through the ureterovesical anastomosis placed by suprapubic bladder puncture (SP stent). From 2011, 236 recipients received an internal double-J (JJ) stent. Results: The rate of UC was 3.8% in JJ stents, compared to 9.3% in SP stents (p = 0.021). No difference in surgical ureter revision rate was observed between the groups (2.1 vs. 5.5%; p = 0.068). Urinary tract infection (UTI) rate and graft function were comparable between both groups. Conclusions: Internal JJ stenting significantly decreased the incidence of UC compared to an external SP stent. There was no difference in surgical ureter revision rate, UTI or graft function.

Keywords:
Kidney transplantation, Urological complications, Ureteral stent, Urinary tract infection
1.
Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-1730.
2.
Zavos G, Pappas P, Karatzas T, Karidis NP, Bokos J, Stravodimos K, et al: Urological complications: analysis and management of 1525 consecutive renal transplantations. Transplant Proc 2008;40:1386-1390.
3.
Neri F, Tsivian M, Coccolini F, Bertelli R, Cavallari G, Nardo B, et al: Urological complications after kidney transplantation: experience of more than 1,000 transplantations. Transplant Proc 2009;41:1224-1226.
4.
Mangus RS, Haag BW: Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: a metaanalysis. Am J Transplant 2004;4:1889-1896.
5.
Wilson CH, Bhatti AA, Rix DA, Manas DM: Routine intraoperative stenting for renal transplant recipients. Transplantation 2005;80:877-882.
6.
Wilson CH, Rix DA, Manas DM: Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 2013;6:CD004925.
7.
Dols LF, Terkivatan T, Kok NF, Tran TC, Weimar W, IJzermans JN, et al: Use of stenting in living donor kidney transplantation: does it reduce vesicoureteral complications? Transplant Proc 2011;43:1623-1626.
8.
Gomes G, Nunes P, Castelo D, Parada B, Patrão R, Bastos C, et al: Ureteric stent in renal transplantation. Transplant Proc 2013;45:1099-1101.
9.
Vaccarisi S, Cannistrà M, Pellegrino V, Cavallari G, Nardo B: Urologic complications in kidney transplantation: a single-center experience. Transplant Proc 2011;43:1074-1075.
10.
Minnee RC, Bemelman FJ, Laguna Pes PP, ten Berge IJ, Legemate DA, Idu MM: Effectiveness of a 5-day external stenting protocol on urological complications after renal transplantation. World J Surg 2009;33:2722-2726.
11.
Fockens MM, Alberts VP, Bemelman FJ, van der Pant KA, Idu MM: Wound morbidity after kidney transplant. Prog Transplant 2015;25:45-48.
12.
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254.
13.
DuBay DA, Lynch R, Cohn J, Ads Y, Punch JD, Pelletier SJ, et al: Is routine ureteral stenting cost-effective in renal transplantation? J Urol 2007;178:2509-2513.
14.
Tavakoli A, Surange RS, Pearson RC, Parrott NR, Augustine T, Riad HN: Impact of stents on urological complications and health care expenditure in renal transplant recipients: results of a prospective, randomized clinical trial. J Urol 2007;177:2260-2264; discussion 2264.
15.
Watson G: Problems with double-J stents and nephrostomy tubes. J Endourol 1997;11:413-417.
16.
Jolly EC, Adshead JM, Farrington K: The retained stent: forgotten but not gone. Kidney Int 2010;77:260.
17.
Lee JR, Bang H, Dadhania D, Hartono C, Aull MJ, Satlin M, et al: Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation 2013;96:732-738.
18.
Harza M, Baston C, Preda A, Olaru V, Ismail G, Domnisor L, et al: Impact of ureteral stenting on urological complications after kidney transplantation surgery: a single-center experience. Transplant Proc 2014;46:3459-3462.
19.
Sinangil A, Celik V, Barlas S, Akin EB, Ecder T: Should transplant ureter be stented routinely or not? Eur Rev Med Pharmacol Sci 2014;18:3551-3556.
20.
Alci E, Ustun M, Sezer T, Yilmaz M, Ozdemir M, Unsal MG, et al: Comparison of patients in whom double-J stent had been placed or not placed after renal transplantation in a single center: a follow-up study. Transplant Proc 2015;47:1433-1436.
21.
Parapiboon W, Ingsathit A, Disthabanchong S, Nongnuch A, Jearanaipreprem A, Charoenthanakit C, et al: Impact of early ureteric stent removal and cost-benefit analysis in kidney transplant recipients: results of a randomized controlled study. Transplant Proc 2012;44:737-739.
22.
Coskun AK, Harlak A, Ozer T, Eyitilen T, Yigit T, Demirbaş S, et al: Is removal of the stent at the end of 2 weeks helpful to reduce infectious or urologic complications after renal transplantation? Transplant Proc 2011;43:813-815.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.